• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢菌素前药抑制剂克服金属β-内酰胺酶驱动的抗生素耐药性。

Cephalosporin Prodrug Inhibitors Overcome Metallo-β-Lactamase Driven Antibiotic Resistance.

机构信息

Biological Chemistry Group, Institute of Biology Leiden, Leiden University, Sylviusweg 72, 2333 BE, Leiden, The Netherlands.

Department of Biology, Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands.

出版信息

Chemistry. 2021 Feb 19;27(11):3806-3811. doi: 10.1002/chem.202004694. Epub 2021 Jan 8.

DOI:10.1002/chem.202004694
PMID:33237604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7986777/
Abstract

The increasing prevalence of metallo-β-lactamase (MBL)-expressing bacteria presents a worrying trend in antibiotic resistance. MBLs rely on active site zinc ions for their hydrolytic activity and the pursuit of MBL-inhibitors has therefore involved the investigation of zinc chelators. To ensure that such chelators specifically target MBLs, a series of cephalosporin prodrugs of two potent zinc-binders: dipicolinic acid (DPA) and 8-thioquinoline (8-TQ) was prepared. Although both DPA and 8-TQ bind free zinc very tightly (K values in the low nm range), the corresponding cephalosporin conjugates do not. The cephalosporin conjugates are efficiently hydrolyzed by MBLs to release DPA or 8-TQ, as confirmed by using both NMR and LC-MS studies. Notably, the cephalosporin prodrugs of DPA and 8-TQ show potent inhibitory activity against NDM, VIM, and IMP classes of MBLs and display potent synergy with meropenem against MBL-expressing clinical isolates of K. pneumoniae and E. coli.

摘要

金属β-内酰胺酶(MBL)表达细菌的患病率不断上升,这是抗生素耐药性方面令人担忧的趋势。MBLs 依赖活性位点的锌离子发挥水解活性,因此,寻找 MBL 抑制剂的研究涉及锌螯合剂。为了确保这些螯合剂能够特异性地靶向 MBLs,我们制备了两种强效锌结合物:二吡啶酸(DPA)和 8-硫代喹啉(8-TQ)的头孢菌素前药。尽管 DPA 和 8-TQ 与游离锌结合非常紧密(K 值在低纳米范围内),但相应的头孢菌素缀合物却不能。通过使用 NMR 和 LC-MS 研究证实,头孢菌素缀合物可被 MBL 高效水解,释放出 DPA 或 8-TQ。值得注意的是,DPA 和 8-TQ 的头孢菌素前药对 NDM、VIM 和 IMP 类 MBL 具有很强的抑制活性,并与美罗培南对产 MBL 的肺炎克雷伯菌和大肠杆菌临床分离株表现出很强的协同作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7202/7986777/400621355bcb/CHEM-27-3806-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7202/7986777/b0e4d090434f/CHEM-27-3806-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7202/7986777/7e237f2f43ad/CHEM-27-3806-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7202/7986777/400621355bcb/CHEM-27-3806-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7202/7986777/b0e4d090434f/CHEM-27-3806-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7202/7986777/7e237f2f43ad/CHEM-27-3806-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7202/7986777/400621355bcb/CHEM-27-3806-g001.jpg

相似文献

1
Cephalosporin Prodrug Inhibitors Overcome Metallo-β-Lactamase Driven Antibiotic Resistance.头孢菌素前药抑制剂克服金属β-内酰胺酶驱动的抗生素耐药性。
Chemistry. 2021 Feb 19;27(11):3806-3811. doi: 10.1002/chem.202004694. Epub 2021 Jan 8.
2
Hydroxyhexylitaconic acids as potent IMP-type metallo-β-lactamase inhibitors for controlling carbapenem resistance in .羟己基衣康酸作为有效的 IMP 型金属 β-内酰胺酶抑制剂,用于控制. 中的碳青霉烯类耐药性。
Microbiol Spectr. 2024 Mar 5;12(3):e0234423. doi: 10.1128/spectrum.02344-23. Epub 2024 Feb 5.
3
Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.磺酰胺杂芳基羧酸作为有前途的金属β-内酰胺酶抑制剂,用于控制细菌碳青霉烯类耐药性。
mBio. 2020 Mar 17;11(2):e03144-19. doi: 10.1128/mBio.03144-19.
4
Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1.吡啶二羧酸衍生物作为新型德里金属β-内酰胺酶-1的抑制剂
J Med Chem. 2017 Sep 14;60(17):7267-7283. doi: 10.1021/acs.jmedchem.7b00407. Epub 2017 Aug 30.
5
Novel Cephalosporin Conjugates Display Potent and Selective Inhibition of Imipenemase-Type Metallo-β-Lactamases.新型头孢菌素缀合物对碳青霉烯酶型金属β-内酰胺酶表现出强大且选择性的抑制作用。
J Med Chem. 2021 Jul 8;64(13):9141-9151. doi: 10.1021/acs.jmedchem.1c00362. Epub 2021 Jun 28.
6
Structural studies of triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-β-lactamases.具有抗抗生素耐药性金属β-内酰胺酶抑制作用的三唑抑制剂的结构研究。
Bioorg Med Chem. 2020 Aug 1;28(15):115598. doi: 10.1016/j.bmc.2020.115598. Epub 2020 Jun 18.
7
Mechanistic Investigations of Metallo-β-lactamase Inhibitors: Strong Zinc Binding Is Not Required for Potent Enzyme Inhibition*.金属β-内酰胺酶抑制剂的作用机制研究:强烈的锌结合对于有效的酶抑制并非必需*。
ChemMedChem. 2021 May 18;16(10):1651-1659. doi: 10.1002/cmdc.202100042. Epub 2021 Mar 3.
8
Synthesis and Preclinical Evaluation of TPA-Based Zinc Chelators as Metallo-β-lactamase Inhibitors.基于TPA的锌螯合剂作为金属β-内酰胺酶抑制剂的合成及临床前评价
ACS Infect Dis. 2018 Sep 14;4(9):1407-1422. doi: 10.1021/acsinfecdis.8b00137. Epub 2018 Aug 2.
9
A Cephalosporin Prochelator Inhibits New Delhi Metallo-β-lactamase 1 without Removing Zinc.头孢菌素螯合剂在不除去锌的情况下抑制新德里金属β-内酰胺酶 1。
ACS Infect Dis. 2020 May 8;6(5):1264-1272. doi: 10.1021/acsinfecdis.0c00083. Epub 2020 Apr 29.
10
Suppression of β-Lactam Resistance by Aspergillomarasmine A Is Influenced by both the Metallo-β-Lactamase Target and the Antibiotic Partner.阿魏酸玛索菌素 A 通过同时抑制金属β-内酰胺酶靶位和抗生素伙伴来抑制β-内酰胺耐药性。
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.01386-19.

引用本文的文献

1
Prodrug activation in malaria parasites mediated by an imported erythrocyte esterase, acylpeptide hydrolase (APEH).由一种导入的红细胞酯酶——酰基肽水解酶(APEH)介导的疟原虫前药激活。
Proc Natl Acad Sci U S A. 2025 Mar 11;122(10):e2417682122. doi: 10.1073/pnas.2417682122. Epub 2025 Mar 4.
2
Approachable Synthetic Methodologies for Second-Generation -Lactamase Inhibitors: A Review.第二代β-内酰胺酶抑制剂的便捷合成方法:综述
Pharmaceuticals (Basel). 2024 Aug 23;17(9):1108. doi: 10.3390/ph17091108.
3
Prodrug activation in malaria parasites mediated by an imported erythrocyte esterase, acylpeptide hydrolase (APEH).

本文引用的文献

1
A Cephalosporin Prochelator Inhibits New Delhi Metallo-β-lactamase 1 without Removing Zinc.头孢菌素螯合剂在不除去锌的情况下抑制新德里金属β-内酰胺酶 1。
ACS Infect Dis. 2020 May 8;6(5):1264-1272. doi: 10.1021/acsinfecdis.0c00083. Epub 2020 Apr 29.
2
Small Molecule Carboxylates Inhibit Metallo-β-lactamases and Resensitize Carbapenem-Resistant Bacteria to Meropenem.小分子羧酸盐可抑制金属β-内酰胺酶并使耐碳青霉烯类细菌对美罗培南重新敏感。
ACS Infect Dis. 2020 Jun 12;6(6):1366-1371. doi: 10.1021/acsinfecdis.9b00459. Epub 2020 Apr 3.
3
Aminocarboxylic acids related to aspergillomarasmine A (AMA) and ethylenediamine-N,N'-disuccinic acid (EDDS) are strong zinc-binders and inhibitors of the metallo-beta-lactamase NDM-1.
由一种导入的红细胞酯酶——酰基肽水解酶(APEH)介导的疟原虫前药激活。
bioRxiv. 2024 Aug 31:2024.08.30.610542. doi: 10.1101/2024.08.30.610542.
4
Current Strategy for Targeting Metallo-β-Lactamase with Metal-Ion-Binding Inhibitors.当前针对金属-β-内酰胺酶的金属离子结合抑制剂的策略。
Molecules. 2024 Aug 21;29(16):3944. doi: 10.3390/molecules29163944.
5
An engineered prodrug selectively suppresses β-lactam resistant bacteria in a mixed microbial setting.一种工程前药在混合微生物环境中选择性抑制β-内酰胺耐药菌。
bioRxiv. 2024 Aug 3:2024.08.02.606422. doi: 10.1101/2024.08.02.606422.
6
New Delhi Metallo-Beta-Lactamase Inhibitors: A Systematic Scoping Review.新德里金属β-内酰胺酶抑制剂:一项系统的范围综述。
J Clin Med. 2024 Jul 18;13(14):4199. doi: 10.3390/jcm13144199.
7
In vitro Activity of Cefepime/Avibactam Against Carbapenem Resistant and Integrative Metabolomics-Proteomics Approach for Resistance Mechanism: A Single-Center Study.头孢吡肟/阿维巴坦对碳青霉烯耐药菌的体外活性及耐药机制的整合代谢组学-蛋白质组学方法:一项单中心研究
Infect Drug Resist. 2023 Sep 11;16:6061-6077. doi: 10.2147/IDR.S420898. eCollection 2023.
8
In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant .β-内酰胺-金属β-内酰胺酶抑制剂的体外和体内研究:针对碳青霉烯类耐药菌。
ACS Infect Dis. 2023 Mar 10;9(3):486-496. doi: 10.1021/acsinfecdis.2c00485. Epub 2023 Feb 14.
9
Towards combating antibiotic resistance by exploring the quantitative structure-activity relationship of NDM-1 inhibitors.通过探索NDM-1抑制剂的定量构效关系来对抗抗生素耐药性。
EXCLI J. 2022 Nov 16;21:1331-1351. doi: 10.17179/excli2022-5380. eCollection 2022.
10
Synthetic Studies with Bacitracin A and Preparation of Analogues Containing Alternative Zinc Binding Groups.杆菌肽 A 的合成研究及含替代锌结合基团类似物的制备。
Chembiochem. 2022 Dec 16;23(24):e202200547. doi: 10.1002/cbic.202200547. Epub 2022 Nov 18.
与 Aspergillomarasmine A (AMA) 和乙二胺二琥珀酸 (EDDS) 相关的氨基羧酸是强锌结合物,也是金属β-内酰胺酶 NDM-1 的抑制剂。
Chem Commun (Camb). 2020 Mar 10;56(20):3047-3049. doi: 10.1039/d0cc00356e.
4
Antibiotic development - economic, regulatory and societal challenges.抗生素研发——经济、监管及社会挑战
Nat Rev Microbiol. 2020 May;18(5):267-274. doi: 10.1038/s41579-019-0293-3. Epub 2019 Nov 19.
5
Development of Ubiquitin-Based Probe for Metalloprotease Deubiquitinases.基于泛素的金属蛋白酶去泛素化酶探针的开发。
Angew Chem Int Ed Engl. 2019 Oct 7;58(41):14477-14482. doi: 10.1002/anie.201906790. Epub 2019 Aug 28.
6
Exploitation of Antibiotic Resistance as a Novel Drug Target: Development of a β-Lactamase-Activated Antibacterial Prodrug.利用抗生素耐药性作为新型药物靶点:β-内酰胺酶激活型抗菌前药的开发。
J Med Chem. 2019 May 9;62(9):4411-4425. doi: 10.1021/acs.jmedchem.8b01923. Epub 2019 May 1.
7
Differential active site requirements for NDM-1 β-lactamase hydrolysis of carbapenem versus penicillin and cephalosporin antibiotics.NDM-1 碳青霉烯酶水解碳青霉烯类与青霉素类和头孢菌素类抗生素的差异活性位点要求。
Nat Commun. 2018 Oct 30;9(1):4524. doi: 10.1038/s41467-018-06839-1.
8
β-lactam/β-lactamase inhibitor combinations: an update.β-内酰胺类/β-内酰胺酶抑制剂联合制剂:最新进展
Medchemcomm. 2018 Aug 17;9(9):1439-1456. doi: 10.1039/c8md00342d. eCollection 2018 Sep 1.
9
Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors.金属β-内酰胺酶的多样性和增殖:呼吁开发临床上有效的金属β-内酰胺酶抑制剂。
Appl Environ Microbiol. 2018 Aug 31;84(18). doi: 10.1128/AEM.00698-18. Print 2018 Sep 15.
10
The Continuing Challenge of Metallo-β-Lactamase Inhibition: Mechanism Matters.金属β-内酰胺酶抑制的持续挑战:机制至关重要。
Trends Pharmacol Sci. 2018 Jul;39(7):635-647. doi: 10.1016/j.tips.2018.03.007. Epub 2018 Apr 18.